Use of postmenopausal hormone replacement therapy and risk of non-Hodgkin's lymphoma: A Danish population-based cohort study

British Journal of Cancer

Volumn 94, Issue 9, 2006, Pages 1339-1341

  Norgaard M ^a   Poulsen, A H ^b   Pedersen, L ^a   Gregersen, H ^c   Friis, S ^b   Ewertz, M ^c   Johnsen, H E ^c   Sorensen H T ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cohort study; Non Hodgkin's lymphoma; Population based study; Postmenopausal hormone replacement therapy; Risk

Indexed keywords

ANDROGEN; ANTIANDROGEN; CLOMIFENE; ESTROGEN; GESTAGEN; ORAL CONTRACEPTIVE AGENT; SEX HORMONE;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; DENMARK; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; NONHODGKIN LYMPHOMA; POPULATION RESEARCH; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; TREATMENT OUTCOME;

ADULT; AGED; COHORT STUDIES; DENMARK; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; INCIDENCE; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; POSTMENOPAUSE; RISK FACTORS;

EID: 33646499904     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603123     Document Type: Article

References (20)

1. Adami HO, Hunter D, Trichopoulos D (2002) Textbook of Cancer Epidemiology, pp 520-572. New York: Oxford University Press
2. Adami HO, Tsaih S, Lambe M, Hsieh C, Adami J, Trichopoulos D, Melbye M, Glimelius B (1997) Pregnancy and risk of non-Hodgkin's lymphoma: a prospective study. Int J Cancer 70: 155-158
3. Askling J, Fored CM, Baecklund E, Brandt L, Backlin C, Ekbom A, Sundstrom C, Bertilsson L, Coster L, Geborek P, Jacobsson LT, Lindblad S, Lysholm J, Rantapaa-Dahlqvist S, Saxne T, Klareskog L, Feltelius N (2005) Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis 64: 1414-2140
4. Bhaskaran K, Brettle R, Porter K, Walker AS (2004) CASCADE Collaboration. Systemic non-Hodgkin lymphoma in individuals with known dates of HIV seroconversion: incidence and predictors. AIDS 18: 673-681
5. Cerhan JR., Vachon CM, Habermann TM, Ansell SM, Witzig TE, Kurtin PJ, Janney CA, Zheng W, Potter JD, Sellers T, Folsom AR (2002) Hormone replacement therapy and risk of non-Hodgkin lymphoma and chronic lymphocytic leukemia. Cancer Epidemiol, Biomarkers Prev 11: 1466-1471
6. Danish Board of Health (2004) Cancer incidence in Denmark 2000. Copenhagen: Danish Board of Health
7. Ewertz M, Mellemkjær L, Poulsen AH, Friis S, Sørensen HT, Pedersen L, McLaughlin JK, Olsen JH (2005) Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study. Br J Cancer 92: 1293-1297
8. Forsberg JG (1984) Short-term and long-term effects of estrogen on lymphoid tissues and lymphoid cells with some remarks on the significance for carcinogenesis. Arch Toxicol 55: 79-90
9. Gaist D, Sørensen HT, Hallas J (1997) The Danish prescription registries. Danish Med Bull 44: 445-448
10. Glaser SL, Clarke CA, Nugent RA, Stearns CB, Dorfman RF (2003) Reproductive factors in Hodgkin's disease in women. Am J Epidemiol 158: 553-563
11. Hjalgrim H, Frisch M, Begtrup K, Melbye M (1996) Recent increase in the incidence of non-Hodgkin's lymphoma among young men and women in Denmark. Br J Cancer 73: 951-954
12. Humphrey LL, Chan BK, Sox HC (2002) Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease. Ann Int Med 137: 273-284
13. Levine PH, Hoover R (1992) The emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiological factors. Cancer Epidemiol, Biomarkers Prev 1: 515-517
14. Løkkegaard EL, Johnsen SP, Heitman BL, Stahlberg C, Pedersen AT, Obel EB, Hundrup YA, Hallas J, Sørensen HT (2004) The validity of self-reported use of hormone replacement therapy among Danish nurses. Acta Obstet Gynecol Scand 83: 476-481
15. Medina KL, Strasser A, Kincade PW (2000) Estrogen influences the differentiation, proliferation, and survival of early B-lineage precursors. Blood 95: 2059-2067
16. Nelson RA, Levine AM, Bernstein L (2001) Reproductive factors and risk of intermediate- or high-grade B-Cell non-Hodgkin's lymphoma in women. J Clin Oncol 19: 1381-1387
17. Olesen AV, Johnsen SP, Mortensen JT, Bøggil H, Olsen J, Sørensen HT (2005) Socioeconomic status and use of postmenopausal hormone replacement therapy among Danish women. Acta Obstet Gynecol Scand 84: 639-644
18. Storm HH, Michelsen EV, Clemmensen IH, Pihl J (1997) The Danish Cancer Registry - history, content, quality and use. Danish Med Bull 44: 535-539
19. Tavani A, Pregnolato A, La Vecchia C, Franceschi S (1997) A case-control study of reproductive factors and risk of lymphomas and myelomas. Leukemia Res 21: 885-888
20. Zinzani PL (2005) Lymphoma: diagnosis, staging, natural history, and treatment strategies. Semin Oncol 32: S4-S10